Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Orexo
Orexo
Orexo is a pharmaceutical company based in Uppsala, Sweden initially financed with venture capital provided by HealthCap.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Zubsolv
Buprenorphine
,
Naloxone
2013-07-03
2024-2038
Septic shock
,
Pain
,
Opioid-related disorders
,
Heroin dependence
,
Respiration disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Buprenorphine
opioid-related disorders
,
substance-related disorders
,
medication adherence
,
addictive behavior
Naloxone
opioid-related disorders
,
substance-related disorders
,
medication adherence
,
addictive behavior
Aspartame
hyperlipidemias
,
gastrointestinal stromal tumors
,
anemia
,
iron-deficiency anemia
,
iron deficiencies
,
glioblastoma
,
gliosarcoma
,
lung neoplasms
,
small cell lung carcinoma
,
healthy volunteers/patients
,
leukemia
,
primary myelofibrosis
,
myeloid leukemia acute
,
myeloid leukemia
,
carcinoma
,
hepatocellular carcinoma
,
diarrhea
,
plexiform neurofibroma
,
neurofibromatoses
,
neurofibroma
,
thalassemia
,
iron overload
,
chronic obstructive pulmonary disease
,
obesity
,
triple negative breast neoplasms
,
pre-eclampsia
,
eclampsia
,
essential thrombocythemia
,
polycythemia vera
,
thrombocytosis
,
polycythemia
,
lupus nephritis
,
nephritis
,
inflammatory breast neoplasms
,
prostatic neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
hemorrhage
,
wiskott-aldrich syndrome
,
bcr-abl positive chronic myelogenous leukemia
,
metaplasia
,
syndrome
,
hyperlipoproteinemia type ii
,
organ transplantation
,
homozygous familial hypercholesterolemia
,
cryopyrin-associated periodic syndromes
,
myelodysplastic syndromes
,
preleukemia
,
liver transplantation
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
parkinson disease
,
eosinophilia
,
cellulitis
,
juvenile arthritis
,
arthritis
,
hepatitis b
,
hepatitis
,
hepatitis b virus
,
hepatitis a
,
macular edema
,
edema
,
vision disorders
,
low vision
,
pituitary acth hypersecretion
,
acth-secreting pituitary adenoma
,
osteoporosis
,
acute coronary syndrome
,
bronchitis
,
acute disease
,
pulmonary eosinophilia
,
pancreatic neoplasms
,
fistula
,
delirium
,
kidney transplantation
,
asthma
,
hypercholesterolemia
,
cardiovascular diseases
,
atherosclerosis
,
chronic kidney failure
,
kidney diseases
,
thrombocytopenia
,
neoplasms
,
breast neoplasms
,
heart failure
,
renal insufficiency
,
infections
,
dyslipidemias
,
chagas disease
,
chronic renal insufficiency
,
renal dialysis
,
renal replacement therapy
,
drug-related side effects and adverse reactions
,
heart transplantation
,
polycystic kidney diseases
,
autosomal dominant polycystic kidney
,
arthrogryposis
,
fibrosis
,
cystic fibrosis
,
pseudomonas infections
,
type 2 diabetes mellitus
,
diabetes mellitus
,
multiple myeloma
,
plasma cell neoplasms
,
transplantation
,
cytomegalovirus infections
,
communicable diseases
,
melanoma
,
schizophrenia
Cam2038
substance-related disorders
,
hepatitis c
,
chronic hepatitis c
,
intravenous substance abuse
,
hepatitis
,
chronic hepatitis
Subutex
substance-related disorders
,
hepatitis c
,
chronic hepatitis c
,
intravenous substance abuse
,
hepatitis
,
chronic hepatitis
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use